David Sommerhalder

Also affiliated with Urology San Antonio, Babcock & Wilcox (United States)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumors”.

Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumors

The Oncologist(2025)10.1093/oncolo/oyaf169

N/A

0DataRank · unranked

4 citations

Farshid Dayyani, David Sommerhalder, Andrae Lavon Vandross, Meredith S. Pelster, Jason T. Henry +9 more